7. Trials for which vaccine efficacy is reported by smaller age subgroups.

Trial	Target age group	Age category	Reported age sub‐groups
Phase2 trial (ph2,1v)	16‐23	younger	none
Phase2 trial (ph2,2v)	15‐25	younger	none
Phase2 trial (ph2,4v)	16‐23	younger	none
Japanese trial (ph2,2v)	20‐25	younger	none
PATRICIA trial (ph3,2v)	15‐25	younger	15‐17, 18‐20, 21‐25
CVT (ph3,2v)	18‐25	younger	18‐19, 20‐21, 22‐23, 24‐25
VIVIANE trial (ph3,2v)	26+	older	26‐35, 36‐45, 46+
FUTURE I trial (ph3,4v)	16‐24	younger	none
FUTURE II trial (ph3,4v)	15‐26	younger	none
FUTURE III trial (ph3,4v)	25‐45	older	none